335 related articles for article (PubMed ID: 32790936)
1. Nicotine and the nicotinic cholinergic system in COVID-19.
Tizabi Y; Getachew B; Copeland RL; Aschner M
FEBS J; 2020 Sep; 287(17):3656-3663. PubMed ID: 32790936
[TBL] [Abstract][Full Text] [Related]
2. Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population?
Olds JL; Kabbani N
FEBS J; 2020 Sep; 287(17):3651-3655. PubMed ID: 32189428
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics.
Beacon TH; Su RC; Lakowski TM; Delcuve GP; Davie JR
IUBMB Life; 2020 Nov; 72(11):2331-2354. PubMed ID: 32936531
[TBL] [Abstract][Full Text] [Related]
4. ACE2-Targeting antibody suppresses SARS-CoV-2 Omicron and Delta variants.
Ou J; Zhang Y; Wang Y; Zhang Z; Wei H; Yu J; Wang Q; Wang G; Zhang B; Wang C
Signal Transduct Target Ther; 2022 Feb; 7(1):43. PubMed ID: 35140198
[No Abstract] [Full Text] [Related]
5. Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications.
Farsalinos K; Eliopoulos E; Leonidas DD; Papadopoulos GE; Tzartos S; Poulas K
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823591
[TBL] [Abstract][Full Text] [Related]
6. Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection.
Zhuang MW; Cheng Y; Zhang J; Jiang XM; Wang L; Deng J; Wang PH
J Med Virol; 2020 Nov; 92(11):2693-2701. PubMed ID: 32497323
[TBL] [Abstract][Full Text] [Related]
7. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review.
Marchi R; Sugita B; Centa A; Fonseca AS; Bortoletto S; Fiorentin K; Ferreira S; Cavalli LR
Infect Genet Evol; 2021 Jul; 91():104832. PubMed ID: 33812037
[TBL] [Abstract][Full Text] [Related]
8. Review of studies of severe acute respiratory syndrome related coronavirus-2 pathogenesis in human organoid models.
Egilmezer E; Rawlinson WD
Rev Med Virol; 2021 Nov; 31(6):e2227. PubMed ID: 33763936
[TBL] [Abstract][Full Text] [Related]
9. Infection of wild-type mice by SARS-CoV-2 B.1.351 variant indicates a possible novel cross-species transmission route.
Pan T; Chen R; He X; Yuan Y; Deng X; Li R; Yan H; Yan S; Liu J; Zhang Y; Zhang X; Yu F; Zhou M; Ke C; Ma X; Zhang H
Signal Transduct Target Ther; 2021 Dec; 6(1):420. PubMed ID: 34907154
[TBL] [Abstract][Full Text] [Related]
10. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
Choudhury A; Mukherjee S
J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
[TBL] [Abstract][Full Text] [Related]
11. Tumor markers as an entry for SARS-CoV-2 infection?
Xia P; Dubrovska A
FEBS J; 2020 Sep; 287(17):3677-3680. PubMed ID: 32738184
[TBL] [Abstract][Full Text] [Related]
12. Nicotinic cholinergic system and COVID-19: In silico identification of interactions between α7 nicotinic acetylcholine receptor and the cryptic epitopes of SARS-Co-V and SARS-CoV-2 Spike glycoproteins.
Lagoumintzis G; Chasapis CT; Alexandris N; Kouretas D; Tzartos S; Eliopoulos E; Farsalinos K; Poulas K
Food Chem Toxicol; 2021 Mar; 149():112009. PubMed ID: 33503469
[TBL] [Abstract][Full Text] [Related]
13. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.
Zalpoor H; Akbari A; Samei A; Forghaniesfidvajani R; Kamali M; Afzalnia A; Manshouri S; Heidari F; Pornour M; Khoshmirsafa M; Aazami H; Seif F
Cell Mol Biol Lett; 2022 Feb; 27(1):10. PubMed ID: 35109786
[TBL] [Abstract][Full Text] [Related]
14. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.
Zhang HL; Li YM; Sun J; Zhang YY; Wang TY; Sun MX; Wang MH; Yang YL; Hu XL; Tang YD; Zhao J; Cai X
J Biol Chem; 2021; 296():100435. PubMed ID: 33610551
[TBL] [Abstract][Full Text] [Related]
15. Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19.
Fu J; Zhou B; Zhang L; Balaji KS; Wei C; Liu X; Chen H; Peng J; Fu J
Mol Biol Rep; 2020 Jun; 47(6):4383-4392. PubMed ID: 32410141
[TBL] [Abstract][Full Text] [Related]
16. Covid-19 and kidney injury: Pathophysiology and molecular mechanisms.
Ahmadian E; Hosseiniyan Khatibi SM; Razi Soofiyani S; Abediazar S; Shoja MM; Ardalan M; Zununi Vahed S
Rev Med Virol; 2021 May; 31(3):e2176. PubMed ID: 33022818
[TBL] [Abstract][Full Text] [Related]
17. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.
Fuentes-Prior P
J Biol Chem; 2021; 296():100135. PubMed ID: 33268377
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis.
Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF
Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423
[TBL] [Abstract][Full Text] [Related]
19. Reply to Cafiero et al. Comment on "Kopańska et al. Disorders of the Cholinergic System in COVID-19 Era-A Review of the Latest Research.
Kopańska M; Szczygielski J; Bartman P; Banaś-Ząbczyk A
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269963
[TBL] [Abstract][Full Text] [Related]
20. How nicotine can inhibit cytokine storm in the lungs and prevent or lessen the severity of COVID-19 infection?
Kloc M; Ghobrial RM; Kubiak JZ
Immunol Lett; 2020 Aug; 224():28-29. PubMed ID: 32522666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
